Skip to content
Search

Latest Stories

Study says UK Covid-19 variant has significantly higher death rate

Study says UK Covid-19 variant has significantly higher death rate

A highly infectious variant of Covid-19 that has spread around the world since it was first discovered in Britain late last year is between 30 per cent and 100 per cent more deadly than previous strains, researchers said on Wednesday (10).

In a study that compared death rates among people in Britain infected with the new SARS-CoV-2 variant, known as B.1.1.7, against those infected with other strains, scientists said the new variant had 'significantly higher' mortality.


The B.1.1.7 variant was first detected in Britain in September 2020, and has since been found in more than 100 countries.

It has 23 mutations in its genetic code - a relatively high number of changes - and some of these have made it far more able to spread. UK scientists say it is about 40-70 per cent more transmissible than previously dominant circulating coronavirus variants.

In the UK study, published in the British Medical Journal on Wednesday, infection with the new variant led to 227 deaths in a sample of 54,906 Covid-19 patients, compared with 141 among the same number of patients infected with other variants.

"Coupled with its ability to spread rapidly, this makes B.1.1.7 a threat that should be taken seriously," said Robert Challen, a researcher at Exeter University who co-led the research.

More For You

Minorities in England face 'lower prescribing rates for diabetes tech'

The disparity is particularly concerning as approximately 5.8 m people across the UK live with diabetes

iStock

Minorities in England face 'lower prescribing rates for diabetes tech'

Highlights

  • Ethnic minorities are less likely to receive continuous glucose monitors despite having higher diabetes rates.
  • People from minority backgrounds make up 17.5 per cent of populations in areas with below-average device prescribing.
  • Ethnicity and deprivation account for up to 77 per cent of variance in diabetes technology prescribing.

People from ethnic minority backgrounds in England have significantly less access to vital diabetes technology, despite being at greater risk of developing the condition, according to groundbreaking research.

The study, published in Diabetic Medicine, reveals that black and south Asian communities face significantly lower prescribing rates for continuous glucose monitors (CGMs) – devices that help people manage their blood glucose levels more effectively than traditional finger-prick tests.

Keep ReadingShow less